Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service colorectal resection cases in Oklahoma: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 5% on average (230 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 7 | 1,071 | 24% |
| 2020 | 7 | 954 | 28% |
| 2021 | 6 | 870 | 34% |
| 2022 | 4 | 841 | 38% |
| 2023 | 10 | 879 | 42% |
| 2024 | 7 | 875 | 44% |
| 2025 from claims | – | 737 596–866 | 46% |
| 2026 forecast | – | 737 577–926 | 46% |
| 2027 forecast | – | 738 548–976 | 47% |
| 2028 forecast | – | 740 524–1,021 | 48% |
| 2029 forecast | – | 741 503–1,062 | 49% |
| 2030 forecast | – | 742 486–1,100 | 49% |
Laparoscopic and open colectomy and proctectomy; stapler, energy, and robotics call point. Professional codes (what the surgeon bills): CPT 44204, 44205, 44207, 44140, 44145, 44160, 45395, 45397; the hospital bills MS-DRG 329, 330, 331.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Oklahoma; 5 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% inpatient hospital.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Texas | 15 | 3,636−5.1%/yr | −5.1%/yr | 1.7 | 0% | 3,880 in 2030+1.1%/yr |
| Florida | 14 | 3,627−6.3%/yr | −6.3%/yr | 1.7 | 0% | 3,630 in 20300%/yr |
| North Carolina | 8 | 1,589−6.5%/yr | −6.5%/yr | 1.6 | 0% | 1,360 in 2030−2.6%/yr |
| Virginia | 8 | 1,510−4.9%/yr | −4.9%/yr | 1.5 | 0% | 1,480 in 2030−0.3%/yr |
| Georgia | 9 | 1,488−6.4%/yr | −6.4%/yr | 1.8 | 0% | 1,450 in 2030−0.4%/yr |
| Tennessee | 8 | 1,264−5.6%/yr | −5.6%/yr | 1.8 | 0% | 1,230 in 2030−0.4%/yr |
| Maryland | 9 | 1,152−4.6%/yr | −4.6%/yr | 1.3 | 0% | 1,300 in 2030+2.1%/yr |
| South Carolina | 6 | 1,082−4.9%/yr | −4.9%/yr | 1.6 | 0% | 1,180 in 2030+1.5%/yr |
| Kentucky | 1 | 825−7.8%/yr | −7.8%/yr | 1.8 | 0% | 700 in 2030−2.7%/yr |
| Alabama | 7 | 775−8.2%/yr | −8.2%/yr | 1.8 | 0% | 760 in 2030−0.3%/yr |
| Louisiana | 3 | 766−7.5%/yr | −7.5%/yr | 1.9 | 0% | 690 in 2030−1.6%/yr |
| Mississippi | 5 | 704−8.2%/yr | −8.2%/yr | 1.9 | 0% | 680 in 2030−0.7%/yr |
| Arkansas | 3 | 698−6%/yr | −6%/yr | 1.9 | 0% | 680 in 2030−0.3%/yr |
| West Virginia | 0 | 265−9.2%/yr | −9.2%/yr | 1.3 | 0% | 200 in 2030−4.7%/yr |
| Delaware | 2 | 264−6.1%/yr | −6.1%/yr | 1.6 | 0% | 340 in 2030+4.1%/yr |
| District of Columbia | 1 | 196−6.3%/yr | −6.3%/yr | 3.2 | 0% | 170 in 2030−2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 30 | 2,570−3.5%/yr | −3.5%/yr | 5.60.9× | 0% | 2,900 in 2030+2.1%/yr |
| Cholecystectomy & appendectomy | 64 | 2,262−6.3%/yr | −6.3%/yr | 4.81.1× | 0% | 2,230 in 2030−0.3%/yr |
| Antireflux & hiatal hernia surgery | 4 | 319−1.5%/yr | −1.5%/yr | 0.70.8× | 0% | 340 in 2030+0.8%/yr |
| Breast reconstruction | 2 | 110−8.8%/yr | −8.8%/yr | 0.20.5× | 0% | 120 in 2030+1.2%/yr |
Colorectal resection in every state, and its device makers · Every procedure market in Oklahoma · Every state · Compare with Texas
Intuitive Surgical leads with 96% of company spending on these surgeons in 2025, +16 pts on 2024.
In 2025, 4 companies reported engagement with Oklahoma’s surgeons worth $108K in consulting, speaking, meals and travel tied to these products, about $15K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 14 clearances and approvals in the category, 12 recalled product lines (1 Class I). A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.